+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ischemia Drug"

Myocardial Ischemia Global Market Report 2024 - Product Thumbnail Image

Myocardial Ischemia Global Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Critical Limb Ischemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Critical Limb Ischemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 136 Pages
  • Global
From
Ischemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Ischemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Critical Limb Ischemia - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Critical Limb Ischemia - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Critical Limb Ischemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Critical Limb Ischemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Brain Ischemia - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Ischemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Critical Limb Ischemia - Pipeline Insight, 2024 - Product Thumbnail Image

Critical Limb Ischemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 208 Pages
  • Global
From
Myocardial Ischemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Myocardial Ischemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2023
  • 113 Pages
  • Global
From
Critical Limb Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Critical Limb Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 125 Pages
  • Global
From
Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 113 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

The Ischemia Drug market is a subset of the Cardiovascular Drugs market, which focuses on drugs used to treat ischemia, a condition caused by reduced blood flow to the heart. Ischemia drugs are used to reduce the risk of heart attack, stroke, and other cardiovascular events. These drugs can be used to treat both acute and chronic ischemia, and can be administered orally, intravenously, or through injections. Common ischemia drugs include antiplatelet agents, anticoagulants, and statins. Ischemia drugs are widely used in the treatment of cardiovascular diseases, and are an important part of the cardiovascular drugs market. Companies in the Ischemia Drug market include Pfizer, Merck, AstraZeneca, Sanofi, and Bristol-Myers Squibb. Show Less Read more